Literature DB >> 28960390

Prenatal Bowel Findings in Male Siblings With a Confirmed FOXP3 Mutation.

Catherine Griswold1, Allison R Durica1, Larry G Dennis1, Ann F Jewell1.   

Abstract

There are multiple etiologies for fetal dilated bowel loops on ultrasonography (US), and we present a unique case of male siblings with a forkhead box P3 (FOXP3) mutation. Both children presented with fetal bowel anomalies on prenatal US. Family histories of cystic fibrosis and immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome were reported. Amniocentesis in both pregnancies identified a normal male karyotype and the familial mutation associated with IPEX syndrome. IPEX syndrome is one of a group of conditions known as congenital diarrhea disorders. Other congenital diarrhea disorder cases have presented with similar prenatal US findings. As a result of these associations, we suggest considering IPEX syndrome as a potential cause of fetal bowel anomalies, particularly with a known family history. However, continued research into the phenotypic and genotypic correlations for IPEX syndrome is likely needed to better understand this possible prenatal presentation.
© 2017 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  FOXP3; IPEX syndrome; congenital diarrhea disorders; dilated bowel loops; fetal ultrasonography; gastrointestinal; genetics; obstetrics

Mesh:

Substances:

Year:  2017        PMID: 28960390     DOI: 10.1002/jum.14428

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  2 in total

1.  A Structure-Guided Delineation of FOXP3 Regulation Mechanism in IPEX.

Authors:  Tengyun Ma; Xiaomin Song; Ciriaco A Piccirillo; Guoping Deng; Mark I Greene
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Intrauterine IPEX.

Authors:  Magda Carneiro-Sampaio; Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Jocelyne Demengeot; Antonio Coutinho
Journal:  Front Pediatr       Date:  2020-11-20       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.